Emisphere Technologies, Inc.
Emisphere Technologies, Inc.
about us product candidates our technology partnered programs investor relations press room home
EMISPHERE® delivery agents
clinical benefits
technology advantages
publications
our technology - publications / published articles
2000

Studies directed at the use of a parallel synthesis matrix to increase throughput in an in vivo assay. Andrea Leone-Bay, John Freeman, Doris O'Toole, Connie Rosado-Gray, Sirpa Salo-Kostmayer, Monica Tai, Frank Mercogliano, Robert A. Baughman, Jr. Journal of Medicinal Chemistry, (2000), 43(19), 3573-3576.

The development of delivery agents that facilitate the oral absorption of macromolecular drugs. Andrea Leone-Bay, Andrea, Duncan R. Paton, John J. Weidner. Medicinal Research Reviews, (2000), 20(2), 169-186.

Treatment of Experimentally Induced Caval Thrombosis with Oral Low-Molecular Weight Heparin and Delivery Agent in Porcine Model of DVT. Annals of Surgery, 2000

Orally Administered Unfractionated Heparin with Carrier Agent is Therapeutic for DVT. Circulation, 2000


1998

Novel delivery agents for mucosal immunization. S. Haas, D. Meleski, T. Kutzy, C. Lercara, D. O’Toole, and H. Leipold. S.T.P. Pharma Sciences 1998


1993

Oral Immunization of rats with protenoid microspheres encapsulating Influenza Virus antigens. Noemi Santiago, Sam Milstein, Theresa Rivera, Elisa Garcia, Tabassum Zaidi, Hyunki Hong and Doris Bucher, Pharmaceutical Research, 1993


published abstracts 2001published abstracts 2001published abstracts 2001